Dr. Hernán Cortés-Funes, Germinal Tumors , Breast cancer, Lung cancer, Head cancer, Neck cancer - Seville, Marbella, Malaga, Cadiz, Cordoba, Granada, Tenerife, Spain

He participated in the Cancer Therapy Evaluation Program at the National Cancer Institute (NCI) in the USA.

Throughout his professional career, he was a foundating member of the Spanish Society of medical Oncology (Spanish SEOM), president of the European Society of Medical Oncology (ESMO), president of the Federation of European Cancer Societies (FECS) and of the Spanish Association of Cancer Research as well as being part of the multiple organizations and cooperative groups, both national and international.

Within the research areas, his interest stands out in the development of new drugs, early clinical studies, clinical pharmacology and new treatments in breast, lung, head and neck cancer and germinal tumors. Dr. Cortés is the author of more than 200 publications in Medical Oncology, collaborator in 14 oncology journals and has written 7 books.

Dr. Cortés-Funes is the author of more than 200 publications in Medical Oncology, collaborator in 14 oncology journals and has written 7 books.

In his career it´s important to highlight also being the president and founder of other Spanish oncology societies such as the International Breast Cancer Research Group (IBGSG), originally called the Ludwig Group and the Cooperative Group for Clinical Research in Breast Cancer and Solid Tumors (Group SOLTI).

He was Head of Oncology service in the “12 de octubre” hospital in Madrid, belongs to the Research Group of the foundation “Fundación 12 de Octubre”, as well as Head of the Oncology Unit by HC Marbella. Except of this he is associate professor of medicine on the Complutense University of Madrid.

Dr. Hernán Cortés-Funes is one of the highest authorities in the country in aspects related to cancer.

Currently: Head of  Oncology Unit 

Publications

Publications in PubMed
More than 150 publications in international indexed journals, in various areas of Medical Oncology, New Drugs, Breast, Lung, Head and Neck Cancer and Germinal Tumors
Impact Factor: 524.57 – Citation Index: 1.076
More than 50 publications in book chapters.
Editor of 11 national and international scientific oncology journals and author and editor of 5 books.